339 related articles for article (PubMed ID: 18834925)
21. MCP-1 in Alzheimer's disease patients: A-2518G polymorphism and serum levels.
Fenoglio C; Galimberti D; Lovati C; Guidi I; Gatti A; Fogliarino S; Tiriticco M; Mariani C; Forloni G; Pettenati C; Baron P; Conti G; Bresolin N; Scarpini E
Neurobiol Aging; 2004 Oct; 25(9):1169-73. PubMed ID: 15312962
[TBL] [Abstract][Full Text] [Related]
22. Tumor necrosis factor-alpha gene promoter polymorphism is not associated with smoking-related COPD in Thailand.
Chierakul N; Wongwisutikul P; Vejbaesya S; Chotvilaiwan K
Respirology; 2005 Jan; 10(1):36-9. PubMed ID: 15691236
[TBL] [Abstract][Full Text] [Related]
23. Variation of the serotonin transporter gene SLC6A4 in the susceptibility to migraine with aura.
Todt U; Freudenberg J; Goebel I; Heinze A; Heinze-Kuhn K; Rietschel M; Göbel H; Kubisch C
Neurology; 2006 Nov; 67(9):1707-9. PubMed ID: 17101915
[TBL] [Abstract][Full Text] [Related]
24. Associations of promoter region polymorphisms in the tumour necrosis factor-alpha gene and early-onset psoriasis vulgaris in a northern Polish population.
Nedoszytko B; Szczerkowska-Dobosz A; Zabłotna M; Gleń J; Rebała K; Roszkiewicz J
Br J Dermatol; 2007 Jul; 157(1):165-7. PubMed ID: 17553030
[TBL] [Abstract][Full Text] [Related]
25. Important differences between human and mouse APOE gene promoters: limitation of mouse APOE model in studying Alzheimer's disease.
Maloney B; Ge YW; Alley GM; Lahiri DK
J Neurochem; 2007 Nov; 103(3):1237-57. PubMed ID: 17854398
[TBL] [Abstract][Full Text] [Related]
26. Genetic association of alpha2-Heremans-Schmid glycoprotein polymorphism with late-onset Alzheimer's disease in Italians.
Geroldi D; Minoretti P; Bianchi M; Di Vito C; Reino M; Bertona M; Emanuele E
Neurosci Lett; 2005 Oct; 386(3):176-8. PubMed ID: 16002217
[TBL] [Abstract][Full Text] [Related]
27. Decreased levels of BDNF protein in Alzheimer temporal cortex are independent of BDNF polymorphisms.
Lee J; Fukumoto H; Orne J; Klucken J; Raju S; Vanderburg CR; Irizarry MC; Hyman BT; Ingelsson M
Exp Neurol; 2005 Jul; 194(1):91-6. PubMed ID: 15899246
[TBL] [Abstract][Full Text] [Related]
28. No evidence for association of the monocyte chemoattractant protein-1 (-2518) gene polymorphism and Alzheimer's disease.
Combarros O; Infante J; Llorca J; Berciano J
Neurosci Lett; 2004 Apr; 360(1-2):25-8. PubMed ID: 15082170
[TBL] [Abstract][Full Text] [Related]
29. CD14 receptor polymorphism and Alzheimer's disease risk.
Combarros O; Infante J; Rodríguez E; Llorca J; Peña N; Fernández-Viadero C; Berciano J
Neurosci Lett; 2005 May 20-27; 380(1-2):193-6. PubMed ID: 15854776
[TBL] [Abstract][Full Text] [Related]
30. A GSTM3 polymorphism associated with an etiopathogenetic mechanism in Alzheimer disease.
Maes OC; Schipper HM; Chong G; Chertkow HM; Wang E
Neurobiol Aging; 2010 Jan; 31(1):34-45. PubMed ID: 18423940
[TBL] [Abstract][Full Text] [Related]
31. Genetic association between polymorphisms in the BTG1 gene and multiple sclerosis.
Camiña-Tato M; Morcillo-Suárez C; Navarro A; Fernández M; Horga A; Montalban X; Comabella M
J Neuroimmunol; 2009 Aug; 213(1-2):142-7. PubMed ID: 19515430
[TBL] [Abstract][Full Text] [Related]
32. Melatonin receptor 1B (MTNR1B) gene polymorphism is associated with the occurrence of adolescent idiopathic scoliosis.
Qiu XS; Tang NL; Yeung HY; Lee KM; Hung VW; Ng BK; Ma SL; Kwok RH; Qin L; Qiu Y; Cheng JC
Spine (Phila Pa 1976); 2007 Jul; 32(16):1748-53. PubMed ID: 17632395
[TBL] [Abstract][Full Text] [Related]
33. Lack of association between VEGF polymorphisms and ALS in a Dutch population.
Van Vught PW; Sutedja NA; Veldink JH; Koeleman BP; Groeneveld GJ; Wijmenga C; Uitdehaag BM; de Jong JM; Baas F; Wokke JH; Van den Berg LH
Neurology; 2005 Nov; 65(10):1643-5. PubMed ID: 16301496
[TBL] [Abstract][Full Text] [Related]
34. No association of CNR1 gene variations with susceptibility to schizophrenia.
Seifert J; Ossege S; Emrich HM; Schneider U; Stuhrmann M
Neurosci Lett; 2007 Oct; 426(1):29-33. PubMed ID: 17881126
[TBL] [Abstract][Full Text] [Related]
35. Is erythropoietin gene a modifier factor in amyotrophic lateral sclerosis?
Ghezzi S; Del Bo R; Scarlato M; Nardini M; Carlesi C; Prelle A; Corti S; Mancuso M; Briani C; Siciliano G; Murri L; Bresolin N; Comi GP
Neurobiol Aging; 2009 May; 30(5):842-4. PubMed ID: 17888545
[TBL] [Abstract][Full Text] [Related]
36. Interleukin-18 promoter polymorphisms and risk of late onset Alzheimer's disease.
Yu JT; Tan L; Song JH; Sun YP; Chen W; Miao D; Tian Y
Brain Res; 2009 Feb; 1253():169-75. PubMed ID: 19073159
[TBL] [Abstract][Full Text] [Related]
37. Tumour necrosis factor-alpha gene polymorphisms and susceptibility to oral lichen planus.
Kimkong I; Hirankarn N; Nakkuntod J; Kitkumthorn N
Oral Dis; 2011 Mar; 17(2):206-9. PubMed ID: 20796230
[TBL] [Abstract][Full Text] [Related]
38. The combinations of TNFalpha-308 and IL-6 -174 or IL-10 -1082 genes polymorphisms suggest an association with susceptibility to sporadic late-onset Alzheimer's disease.
Vural P; Değirmencioğlu S; Parildar-Karpuzoğlu H; Doğru-Abbasoğlu S; Hanagasi HA; Karadağ B; Gürvit H; Emre M; Uysal M
Acta Neurol Scand; 2009 Dec; 120(6):396-401. PubMed ID: 19744138
[TBL] [Abstract][Full Text] [Related]
39. Lack of association of interleukin-1beta polymorphism with Alzheimer's disease in the Jewish population.
Rosenmann H; Meiner Z; Dresner-Pollak R; Kahana E; Aladjem Z; Grenader T; Wertman E; Abramsky O
Neurosci Lett; 2004 Jun; 363(2):131-3. PubMed ID: 15172100
[TBL] [Abstract][Full Text] [Related]
40. The MCP-1 gene (SCYA2) and mood disorders: preliminary results of a case-control association study.
Altamura AC; Mundo E; Cattaneo E; Pozzoli S; Dell'osso B; Gennarelli M; Vergani C; Trabattoni D; Arosio B; Clerici M
Neuroimmunomodulation; 2010; 17(2):126-31. PubMed ID: 19923858
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
